Expertise in
15
conditions

Roger S. Mcintyre

399 Bathurst St 9MP-325, 
Toronto, ON, CA 
Expertise in
15
conditions
399 Bathurst St 9MP-325, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Roger Mcintyre practices in Toronto, Canada. Mr. Mcintyre is highly rated in 15 conditions, according to our data. His top areas of expertise are Bipolar Disorder (BPD), Major Depression, Schizophrenia, and Obesity.

His clinical research consists of co-authoring 1081 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

399 Bathurst St 9MP-325, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Vortioxetine for Cognitive Deficits in Persons With Post-COVID-19 Condition
Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Vortioxetine for Cognitive Deficits in Persons With Post-COVID-19 Condition
Enrollment Status: Completed
Publish Date: January 16, 2025
Intervention Type: Drug
Study Drug: Vortioxetine
Study Phase: Phase 2
The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study
The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study
Enrollment Status: Completed
Publish Date: July 27, 2023
Intervention Type: Drug
Study Drug: Psilocybin
Study Phase: Phase 2
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Enrollment Status: Completed
Publish Date: April 24, 2023
Intervention Type: Drug
Study Drug: Psilocybin
Study Phase: Phase 2
A Multisite, Fixed Dose, Randomized, Double-Blind, Placebo-Controlled 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for the Treatment of Bipolar I/II Depression
A Multisite, Fixed Dose, Randomized, Double-Blind, Placebo-Controlled 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for the Treatment of Bipolar I/II Depression
Enrollment Status: Completed
Publish Date: July 28, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
A Validation Study of a Mobile Phone Digit Symbol Substitution Test Application for Cognition in Adults With Major Depressive Disorder
A Validation Study of a Mobile Phone Digit Symbol Substitution Test Application for Cognition in Adults With Major Depressive Disorder
Enrollment Status: Completed
Publish Date: July 08, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 4 Less Clinical Trials

1081 Total Publications

Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
Journal: The American journal of psychiatry
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mcintyre's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile